Magnetic Resonance in Medicine · 1998 · 48 citations · 36 references
Life SciencesBiochemistryNeuroscienceNeurochemistryNeurophysiologySpectroscopic AnalysisBrain Energy MetabolismBrain ImagingCerebral PhysiologyMagnetic Resonance SpectroscopyMetabolite ProfilingMetabolite QuantificationCerebral Metabolic RateIn Vivo Nmr SpectroscopyMetabolite Distribution AnalysisMetabolite ImagingNuclear Magnetic Resonance QuantificationNuclear Magnetic Resonance Spectroscopy Data AnalysisNuclear Magnetic Resonance Spectroscopy-based Metabolite ProfilingSensitivity
31P NMR is commonly used to study brain energetics in health and disease. Due to sensitivity constraints, the NMR measurements are typically made in volumes that do not contain pure gray or white matter. For accurate evaluation of abnormalities in brain metabolite levels, it is necessary to consider the differences in normal levels of 31P metabolites in gray and white matter. In this study, voxels from a three-dimensional spectroscopic image acquisition were analyzed for their dependence on tissue type to assess differences in metabolite levels between gray and white matter. Specifically, gray matter was found to have significantly higher ratios of phosphocreatine (PCr) to gamma-ATP and PCr to the total 31P metabolite signal, whereas pH and the ratio of PCr to inorganic phosphate (Pi) were found to differ insignificantly between gray and white matter. Thus, tissue type can be an important factor to consider for alterations in bioenergetics by 31P NMR spectroscopic studies of the brain.
36
Cerebral intracellular pH by <sup>31</sup> P nuclear magnetic resonance spectroscopy
Ognen A. C. Petroff, James W. Prichard, Kevin L. Behar et al. · Neurology · 1985 · 530 citations
Imaging at high magnetic fields: initial experiences at 4 T.
Kǎmil Uǧurbil, Michael Garwood, Jutta Ellermann et al. · PubMed · 1993 · 286 citations
Medicine, Neuroscience, Radiology +17